ARCHIVES

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

This article is from The Cancer Letter archive.

Vol. 31 No. 07 | February 18, 2005

Download PDF Visit The Full Archive

Related Articles

White House Backs Down FY 86 Cuts, Says Now They Will Be Limited To Trimming Indirect Costs

January 10, 1986

Pilot Study Tests Novel “Metronomic” Delivery

December 30, 2005

Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors.

February 23, 2007

Celebrex Studies Show Polyp Reduction, Point To Challenges In Biomarker Validation

April 28, 2006

Caution Advised for Hormone Replacement Therapy

March 21, 1986

NCAB Urges $2 Tax On Cigarettes To Reduce Smoking

February 12, 1993